Subscribe to the Wall Street Grapevine Newsletter Now and Get Free Alerts On Stocks Ready To Explode!

By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Kiromic BioPharma Inc. (NASDAQ:KRBP) Stock Gains Further Momentum: Now What?

Kiromic BioPharma Inc. (NASDAQ:KRBP) jumped 14% after rising 33.65% on Monday with over 45374 shares exchanging hands less the stock’s daily average trading volume of 210,000 shares in the past 50 days. The stock is up 6.85% in the last five days, but it is down 69.83% in a month.

For the past three months, the stock has lost 62.63% of its value, and year to date, KRBP has shed 63.19%. The latest jump can be attributed to the acquisition of InSilico Solutions.

KRBP’s R&D group’s target InSilico has been in a long-term collaboration with clients at the National Cancer Institute, Johns Hopkins School of Medicine, and MD Anderson Cancer Center. Following the acquisition, Kiromic will use bioinformatics expertise in-house to expand its positioning AI tech development for optimal biomarkers identification necessary for the latest immunotherapies such as CAR-T cell therapy. For example, most CAR-T developers currently employ biomarkers with poor clinical results from old target libraries in use. So in the coming months, KRBP stock is worth keeping an eye on.

Market Reaction:

On Wednesday, KRBP stock increased 14% at $3.26 with more than 475k shares, compared to its average volume of 258k shares. The stock has moved within a range of $2.7200 – 3.3400 after opening the trade at $2.91. Over the past 52-week, the stock has been trading within a range of $2.7100 – 18.5000.

Published by Madison Hall

After graduating from the University of Buffalo, Madison gained a real interest in the markets. She tends to be a swing trader and enjoys Pilates and yoga in her downtime.

Subscribe to the Wall Street Grapevine Newsletter Now and Get Free Alerts On Stocks Ready To Explode!

By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Subscribe to the Wall Street Grapevine Newsletter Now and Get Free Alerts On Stocks Ready To Explode!

By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact
*By submitting your information you agree to the terms of our Privacy Policy. You will receive the DRP Journal newsletter, and third party offers. You can unsubscribe anytime by selecting unsubscribe at the bottom of our emails.